The New England Journal of Medicine (NEJM) is a weekly general medical journal that publishes new medical research and review articles, and editorial opinion on a wide variety of topics of ...

Nov 27, 2025 · Explore the current issue of The New England Journal of Medicine (Vol. 393 No. 21).

Nov 29, 2025 · Explore this issue of The New England Journal of Medicine (Vol. 0 No. 0).

Explore Original Article articles from The New England Journal of Medicine

The New England Journal of Medicine (NEJM) is recognized as the world’s leading medical journal and website. Published continuously for over 200 years, NEJM delivers high-quality, peer-reviewed ...

NEJM uses highly rigorous editorial, peer, and statistical review processes to evaluate manuscripts for scientific accuracy, novelty, and importance.

NEJM seeks submissions of original research, reviews, case reports, and commentaries that improve patient care and clinical practice, or that offer new information about the biology of disease.

Sep 9, 2024 · Depemokimab is an ultra-long-acting biologic therapy with enhanced binding affinity for interleukin-5 that may enable effective 6-month dosing intervals. In these phase 3A, randomized, …

A 70-year-old man presented with several hours of shortness of breath and a slow heart rate that had been detected by the ballistocardiographic monitor in his commercial mattress.

Jun 1, 2025 · Methods In this phase 3, randomized trial conducted at 55 centers, we assigned patients with resected colon cancer who had completed adjuvant chemotherapy to participate in a structured …